Procoralan ivabradine regulatory update

EMA’s CHMP recommended measures to reduce the risk of heart problems, such as heart attack and bradycardia, in

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE